BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-263@pharmaconomics
DTSTAMP:20260707T013626Z
DTSTART;VALUE=DATE:20260421
DTEND;VALUE=DATE:20260422
SUMMARY:IONS Phase 3 — zilganersen
DESCRIPTION:Phase 3 trial results for zilganersen in Alexander disease are due Apr 21\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/874015/000114036126015801/ef20071051_8k.htm\n\nTrack it: https://pharmaconomics.com/e/263
URL:https://pharmaconomics.com/e/263
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:IONS catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR